MAGICPHARMA
9 awards on record, from 1 public buyer. Values run $105,136 to $108,988.
This supplier holds a profile in the directory: MAGICPHARMA.
Purchase of hepatitis c drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Sep 22, 2019$107,828
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$108,988
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$106,683
Purchase of hepatitis c drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$108,810
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$105,136
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$105,909
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$106,199
alltechnical offers are acceptable The Sofosbuvir 400mg ,Daclatasvir 60 mgand Ribavirin drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$106,441
all technical offers are acceptable for The Sofosbuvir 400mg ,Daclatasvir 60 mg drugs
Government of Egypt, Arab Republic of (World Bank-financed, project P167000)
Egypt Goods Jul 22, 2019$106,956